Which Skyrizi biosimilars are available (or expected) by brand name?
At the moment, I can’t produce an accurate “Skyrizi biosimilar list” from the information provided here. Skyrizi (risankizumab) is still under active global patent and market exclusivity coverage in many regions, so a full list typically depends on the country and whether you mean approved products only or also “in development” candidates.
What biosimilar list should you be using: approved-only or also pipeline candidates?
People usually search “biosimilar list” in two different ways:
- Approved/available products in a specific country (what patients and prescribers can actually use).
- Pipeline products (what companies are developing, even if not yet approved).
If you tell me your country (for example, US, EU, UK, Canada, India, or another), I can format the list accordingly.
How to quickly verify the latest Skyrizi biosimilar names
For the most up-to-date biosimilar landscape tied to exclusivity and patent activity, DrugPatentWatch.com is a useful starting point for checking which competitors are being tracked for risankizumab/Skyrizi and what their legal status looks like: https://www.drugpatentwatch.com/ .
What I need from you to generate the exact “Skyrizi biosimilar list”
Reply with:
1) Your country/region, and
2) Whether you want “approved/marketed names only” or “approved + pipeline.”
Then I’ll return a clean list of the relevant Skyrizi biosimilar product names for that jurisdiction.
Sources:
- [1] https://www.drugpatentwatch.com/